Nuvilex Inc (GREY:NVLX)

a Green Company believing in �Good for You, Good for the Environment.� We continue our paradigm shift to expand our natural product lines while we make important strides in the biotechnology arena.  Our recent acquisition of a live cell encapsulation treatment technology designed to combat pancreatic cancer that has already completed a Phase II clinical trial is actively being prepared for the next stage of development.  Other natural product, biotechnology and clinical advances are already aggressively being pursued at Nuvilex and new updates will be announced shortly.  Please make sure to check the newly launched website (www.nuvilex.com) including purchasing all Nuvilex products directly from the website and new offerings never previously available.  Current products include Cinnergen�, Cinnechol�, and Cinnsational� to enhance a healthy lifestyle; Talsyn� and NumaDerm� for cosmetic use; Reme-Flu�, Legacy Biotechnologies� flu combating regimen; Virgin� and Infinitink�, heavy-metal-free tattoo inks; and additional developments are ongoing for Citroxin� and Oraphyte�, Nuvilex�s antimicrobial and antinematodal agents.